Therapy for Improving Vascular Function in Diabetes

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43HL075926-01
Agency Tracking Number: HL075926
Amount: $128,203.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solicitation Year: 2004
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Small Business Information
ARGINOX PHARMACEUTICALS, INC.
ARGINOX PHARMACEUTICALS, INC., 120 CONSTITUTION DR, STE B, MENLO PARK, CA, 94025
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 PAUL Lane
 (650) 324-5153
 PLANE@ARGINOX.COM
Business Contact
 KEN DRAZEN
Phone: (650) 324-5150
Email: KEN@JUVENTIS.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): ArgiNOx is a recently-formed Wisconsin-based biotech startup that seeks to develop novel therapies for cardiovascular and inflammatory conditions resulting from insufficient or excess nitric oxide (NO). In the cardi

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government